Bristol-Myers Squibb D&A decreased by 3.4% to $977.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 48.0%, from $1.88B to $977.00M. Over 4 years (FY 2021 to FY 2025), D&A shows a downward trend with a -21.7% CAGR.
Higher levels typically reflect significant historical capital expenditures or acquisitions that are now being expensed over time.
This metric represents the non-cash accounting charges used to allocate the cost of tangible assets and intangible asset...
Capital-intensive hardware manufacturers generally show higher D&A relative to revenue than pure-play software companies.
cf_depreciation_and_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.71B | $2.73B | $2.58B | $2.58B | $2.58B | $2.59B | $2.52B | $2.43B | $2.43B | $2.44B | $2.46B | $2.53B | $2.60B | $2.59B | $1.88B | $1.01B | $1.01B | $1.01B | $977.00M |
| QoQ Change | — | +0.6% | -5.4% | +0.2% | -0.0% | +0.2% | -2.6% | -3.6% | +0.1% | +0.1% | +1.2% | +2.8% | +2.5% | -0.2% | -27.5% | -46.2% | -0.1% | +0.0% | -3.4% |
| YoY Change | — | — | — | — | -4.8% | -5.1% | -2.2% | -6.0% | -5.8% | -5.9% | -2.3% | +4.2% | +6.7% | +6.4% | -23.7% | -60.0% | -61.1% | -61.0% | -48.0% |